Evidence map›Paper›PMID 41991935›Full record

ArticleNature communications2026

Immune-induced TCR-like antibodies regulate specific T cell response in mice.

Kazuki Kishida, Keisuke Kawakami, Hiroaki Tanabe, Wataru Nakai, Koji Yonekura, Shigeyuki Yokoyama, Hisashi Arase

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuki KishidaDepartment of Immunochemistry, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, Japan.
Keisuke KawakamiBiostructural Mechanism Group, RIKEN SPring-8 Center, Hyogo, Japan.ORCID 0000-0002-1689-1819
Hiroaki TanabeDepartment of Drug Target Protein Research, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Wataru NakaiDepartment of Immunochemistry, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, Japan.
Koji YonekuraBiostructural Mechanism Group, RIKEN SPring-8 Center, Hyogo, Japan.ORCID 0000-0001-5520-4391
Shigeyuki YokoyamaDepartment of Drug Target Protein Research, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Hisashi AraseDepartment of Immunochemistry, Research Institute for Microbial Diseases, The University of Osaka, Suita, Osaka, Japan. arase@biken.osaka-u.ac.jp.ORCID 0000-0002-1153-3166

Funding

Japan Agency for Medical Research and Development (AMED) 223fa627002Japan Agency for Medical Research and Development (AMED) JP24ama121006Japan Agency for Medical Research and Development (AMED) JP25ek0410124MEXT | Japan Science and Technology Agency (JST) JPMJMI23G2MEXT | Japan Society for the Promotion of Science (JSPS) 22H04989
6 · The paper itself

Abstract

Antigen-specific regulation of T cell response is crucial for limiting hyperimmune response. However, the molecular mechanisms governing specific immune regulation remain unclear. In this study, we discover that antibodies specific to the antigen peptide-MHC class II complex are produced during helper T cell responses to various antigens, including hen egg lysozyme and proteolipid protein peptide. These antibodies specifically inhibit T cell receptor (TCR) recognition of MHC class II molecules presenting specific antigen peptide. We term these antibodies 'immune-induced TCR-like antibodies' or iTabs. Immunization with peptides containing flanking residues induces iTabs whereas immunization with peptides lacking flanking residues does not. Furthermore, we show that immunization with iTab-inducible peptide or iTab treatment suppress autoimmune disease development in a mouse model of experimental autoimmune encephalomyelitis. Thus, our findings provide a strategy for suppressing antigen-specific helper T cell responses using specific peptides, potentially controlling autoimmune diseases.

Indexed as

AntibodiesEncephalomyelitis, Autoimmune, ExperimentalReceptors, Antigen, T-CellT-LymphocytesT-Lymphocytes, Helper-InducerAnimalsFemaleHistocompatibility Antigens Class IIImmunizationMiceMice, Inbred C57BLMuramidaseMyelin Proteolipid ProteinPeptidesAntibodieshen egg lysozymeHistocompatibility Antigens Class IIMuramidaseMyelin Proteolipid ProteinPeptidesReceptors, Antigen, T-Cell

Identifiers

PMID41991935
PMCPMC13087043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.